<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>生物制药小编 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-08T07:34:01+08:00</updated>
  <subtitle>“新起点，再出发”——生物医药小编与您共同关注生物制药行业热点。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>抗体靶点对于ADC药代动力学的影响</title>
    <updated>2021-01-07T17:53:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/KH5AnItkWBeUg78-ymsZbg</id>
    <link href="https://mp.weixin.qq.com/s/KH5AnItkWBeUg78-ymsZbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>游方和尚专栏 | 大分子生物分析概论（十一）： LBA测试中的稳定性问题及最佳实践</title>
    <updated>2021-01-06T15:32:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/ZOOKUITtGdAg_r2_UoNqxg</id>
    <link href="https://mp.weixin.qq.com/s/ZOOKUITtGdAg_r2_UoNqxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>传统药企如何转型大分子新药研发</title>
    <updated>2021-01-06T15:32:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/6NUVVALrkspODfuzTUc0xg</id>
    <link href="https://mp.weixin.qq.com/s/6NUVVALrkspODfuzTUc0xg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年国内细胞治疗产品受理及获批情况及浅析</title>
    <updated>2021-01-06T07:43:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/-eaR6ScbgSEAUAd8TuAAsA</id>
    <link href="https://mp.weixin.qq.com/s/-eaR6ScbgSEAUAd8TuAAsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免疫治疗奠基之路——抗体Fc工程化改造</title>
    <updated>2021-01-06T07:43:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/-N7V9zpYKTWhcRyjKJ2Jnw</id>
    <link href="https://mp.weixin.qq.com/s/-N7V9zpYKTWhcRyjKJ2Jnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Tubulis的ADC组合快速筛选技术</title>
    <updated>2021-01-04T16:19:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/SBthlDWQ6s-Z1bl6SMo4FQ</id>
    <link href="https://mp.weixin.qq.com/s/SBthlDWQ6s-Z1bl6SMo4FQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基于共刺激分子4-1BB的双特异性抗体</title>
    <updated>2021-01-03T09:16:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/HDbUF86ooJVeOMH79kuu4g</id>
    <link href="https://mp.weixin.qq.com/s/HDbUF86ooJVeOMH79kuu4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TILs-TCR工程改造技术要点</title>
    <updated>2021-01-02T16:48:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/063DORva7l4Z-RC5MtfCAA</id>
    <link href="https://mp.weixin.qq.com/s/063DORva7l4Z-RC5MtfCAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>简评靶向GPCR的临床在研抗体</title>
    <updated>2021-01-01T19:37:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/A-r-ofBdVdd-kCRBlYL4hA</id>
    <link href="https://mp.weixin.qq.com/s/A-r-ofBdVdd-kCRBlYL4hA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基于PD-1/L1的双特异抗体突破在何方？</title>
    <updated>2020-12-31T16:47:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/wLmY9E455wrSVsSMDOkAwQ</id>
    <link href="https://mp.weixin.qq.com/s/wLmY9E455wrSVsSMDOkAwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物今年延续强势</title>
    <updated>2020-12-30T14:35:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/Q5I93s-fDlABJ8ue0L8zWQ</id>
    <link href="https://mp.weixin.qq.com/s/Q5I93s-fDlABJ8ue0L8zWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三大抗体工程技术改善抗体药代动力学特性</title>
    <updated>2020-12-29T16:57:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/GBkoBwsGpgxjxS5Ew0Mx9Q</id>
    <link href="https://mp.weixin.qq.com/s/GBkoBwsGpgxjxS5Ew0Mx9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百抗大战</title>
    <updated>2020-12-29T16:57:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/3Rjjvp_C8aVqiP5m5HHL2g</id>
    <link href="https://mp.weixin.qq.com/s/3Rjjvp_C8aVqiP5m5HHL2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>